/home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
">
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
Warning: Attempt to read property "cat_name" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 153
Pulsara Platform Part of Duke Clinical Research Institute (DCRI) IMPROVE Stroke Care Project
With aligned goals, Pulsara partners with DCRI to optimize stroke care
in the United States
BOZEMAN, Mont.–(BUSINESS WIRE)–Pulsara
announced it is a partner in DCRI’s IMPROVE Stroke Care Project.
Pulsara’s mission and purpose are aligned with the goals of the DCRI
project. Pulsara, the leader in regional systems of care communications,
has demonstrated reduced treatment times for stroke patients by
facilitating communication across multiple healthcare entities,
including: EMS, partner hospitals, and Comprehensive Stroke Centers that
act as a hub for a region.
Drs. Brad Kolls, MD, PhD and Carmen Graffagnino, MD are the principal
investigators for IMplementation of best PRactices fOr
acute stroke care – developing and optimizing regional systems of Stroke
Care (IMPROVE Stroke Care) Project.
The aim is to increase the rate and speed of cerebral reperfusion
therapy administration through improvement of care systems in
progressive stroke networks in the geography of the highest rates and
deaths for stroke in the United States — the “stroke belt.” The primary
vision for the IMPROVE Stroke Care project is to improve clinical
outcomes by identifying the optimal processes of stroke care delivery
through sharing data on performance and best practice allowing redesign
of systems within the partnered networks in 7 regional geographies.
This initiative will focus first on establishing a model of acute stroke
regional systems of care through the networks, engineering the emergency
response system with data measurement and feedback to all members of the
stroke team. The IMPROVE Stroke program will also determine what optimal
acute treatment processes are associated with the best functional and
clinical outcomes, and feed these back to our participating partners. In
tandem with the primary aims, the project will assess the community
awareness of the signs and symptoms of stroke, the response in calling
9-1-1 for rapid emergency care, and patterns of stroke treatment.
“Pulsara is excited to participate in the DCRI IMPROVE Stroke Care
project because we see it as an opportunity to leverage our track record
of success and experience facilitating regional communication networks
for stroke, to collect meaningful and actionable data,” said Erich
Hannan, Pulsara’s CTO. “In partnership with DCRI, that data will
generate knowledge for the industry about the evidence-based standards
of care for stroke, and ultimately, help improve stroke patient
outcomes.”
There is great disparity of care across the Southeastern “stroke belt”
of the U.S. We will specifically assess and target gaps identified in
the strategic assessment phase with chosen hub partner networks. The
project will also assess the impact of novel communication tools and
data capture approaches on the efficiency of both care delivery and the
data collection around care processes to help establish new, more
efficient data collection approaches.
Dr. Kolls, Co-Principal investigator, commented, “The development of
automated data capture for care delivery is a necessity. Many centers
are seeing patients using telemedicine to help deliver optimal stroke
care at local facilities. These digital care systems provide the
opportunity to capture information about how decisions are made and when
and how care is delivered in an automated way. Thankfully, we have found
some tremendous industry partners, like Pulsara, to help us pilot this
idea and provide proof that we can automate data collection; saving time
and effort in establishing and monitoring best practices for care
delivery for stroke today, and other conditions in the future.”
ABOUT PULSARA
Pulsara provides a real-time communication network across an entire
region. The Pulsara platform, built on the power of mobile technology,
unites the right clinicians at the right time for the right patient —
providing transparency and streamlined communication. Simply CREATE a
dedicated patient channel. BUILD the team. And, COMMUNICATE using audio,
video, instant messaging, data, images, and key benchmarks. Studies
report an average decreased treatment time of nearly 30% when using
Pulsara. Pulsara is the evidence-based standard of care. For more
information, visit https://www.pulsara.com.
Contacts
Kris Kaull
[email protected]
406.600.0969
Warning: Undefined array key 0 in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493
Warning: Attempt to read property "cat_ID" on null in /home/grassnews/public_html/wp-content/themes/zox-news/parts/post-single.php on line 493
Cannabis
North America Legal Cannabis Industry Report 2024: Market to Grow at a CAGR of 26.65% During 2023-2032, Bank Loans Boosting Business Growth
Cannabis
Global Legal Marijuana Strategic Business Report 2024: A $125+ Billion Market by 2030 Featuring Aphria, Aurora Cannabis, Beacon Medical, Canopy Growth, Cronos, OrganiGram, Tikun Olam, Tilray, Wayland
Cannabis
Avicanna Announces Results of Study in Patients with Epidermolysis Bullosa
-
Cannabis2 weeks ago
Technological Advancements in Breathalyzers Drive Market Growth and Enhance Road Safety
-
Humboldt2 weeks ago
Humboldt Seed Company partners with Apollo Green to bring California cannabis genetics to the global marketplace
-
SCHWAZZE2 weeks ago
Schwazze Sets First Quarter 2024 Conference Call for May 15, 2024 at 5:00 p.m. ET
-
Cannabis2 weeks ago
Bay Area Social Equity Operator Launches the Purple Raina Balm Wand 1:1, an Inclusive Multipurpose Cannabis Topical
-
Cannabis2 weeks ago
Sannabis, Inc. (OTC: USPS) Announces First Shipment of Cannabis Essential Oil from Colombia to U.S. to Fill First Order, as the DEA Re-Classifies Marijuana from Schedule I to Schedule III
-
Cannabis6 days ago
IM Cannabis Reports First Quarter Financial Results
-
Cannabis5 days ago
Mikra Announces Partnership with Virun NutraBiosciences Inc. and Releases CELLF 2.0
-
Innocan5 days ago
Innocan Pharma Reports Breakthrough in a Pre-Clinical Trial: Liposomal-CBD Injection Restores Mobility to an Amputee Female Donkey